Form D · Hedge Fund
Vasuda Life Sciences Fund
Andover, MA · CIK 0001619277
Offering snapshot reported Apr 5, 2016 · SEC filing
- Reported sold
- Yet to sell Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 1
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2016 | Amendment | Yet to sell | No comparison | 1 | SEC filing |
| Oct 21, 2015 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Sep 11, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06c, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-224554
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Bhavneesh Sharma | 6266374 |
Source: Form D, filed Apr 5, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bhavneesh Sharma | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
135 North Street
Andover, MA, 01810
Andover, MA, 01810